Disease Area Diagnostics & prognostics

Variant Database Collaborations – for Cancer and Beyond

| Obi Griffith and Heidi Rehm

It's important to research relevant academic papers, but it's equally important to make sure it's still relevant

Tools & Techniques Omics

Translational Proteomics: Solving the Reproducibility Riddle

| David Chiang

Data analysis in proteomics is not fit for purpose – but here’s how we can get on track

Research Field Neuroscience

VEGF Veteran

| Napoleone Ferrara

Napoleone Ferrara, Distinguished Adjunct Professor of Ophthalmology, UC San Diego School of Medicine, California, USA.

Research Field Cell & gene therapy

The Best Treatment

| Ruth Steer

Is gene therapy the answer to an untreatable form of macular degeneration?

Outside the Lab Analytical science

Faster for Pharma

| Melissa Hanna-Brown

Sitting Down With... Melissa Hanna-Brown, Analytical Technology & Innovation Lead, Pfizer Global R&D, Sandwich, UK.

Outside the Lab Drug discovery

A Problem Shared…

| Roisin McGuigan

It’s time for pharma to join the crowdsourcing revolution.

Disease Area Cancer

Anticipating NRAS Resistance

| William Aryitey

How researchers are unraveling the mystery of melanoma drug resistance

Tools & Techniques Cancer

The Esophageal Balloon

| Sanford Markowitz

The story behind an inflatable pill and a sensitive biomarker that pair up to improve screening for Barrett’s esophagus – and help prevent a highly aggressive cancer

Research Field Drug discovery

Through the Looking Glass

| Niek Buurma

There is a shocking lack of attention given to racemization in drug discovery, despite it having huge implications on the efficacy – and safety – of drugs. We hope the tool we have developed will be the first step towards change.

Disease Area Pain & critical care

Hurt Blocker

| James Strachan

Researchers develop a new way to tackle pain: inhibition of RNA-protein interactions

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register